HOME › DRUGS › LERIGLITAZONE
ACTIVE SUBSTANCE / INN

LERIGLITAZONE

Brand name(s): Nezglyal
EMA LISTED
REFUSED
Adrenoleukodystrophy
ACTIVE SUBSTANCE
Leriglitazone
REGULATORS
EMA
SPONSORS / MAH
Minoryx Therapeutics S.L.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NezglyalMinoryx Therapeutics S.L.RefusedAdrenoleukodystrophy

FULL INTELLIGENCE ON LERIGLITAZONE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →